IGF2BP1 and lung carcinoma: The analysis indicates that many RNAs downregulated by AVJ16 treatment are significantly enriched in gene sets associated with transformed phenotypes and signaling pathways activated during cancer progression, in accordance with known roles of IGF2BP1 in lung carcinoma.